Liquid biopsy: novel technologies and clinical applications

Abstract: “Liquid biopsy” was introduced as a new diagnostic concept in 2010 for the analysis of circulating tumor cells (CTCs) and has been now extended to material (in particular DNA) released by tumor cells in the peripheral blood of cancer patients. Over the past decade, various methods have been developed to detect CTCs and ctDNA in the peripheral blood of cancer patients.

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: Online-Ressource
• Language: Englisch

References and Relationships

• Bibliographic citation: Liquid biopsy: novel technologies and clinical applications ; volume:57 ; number:3 ; year:2019 ; pages:312-316 ; extent:5 ; Clinical chemistry and laboratory medicine ; 57, Heft 3 (2019), 312-316 (gesamt 5)

Contributors, Places and Time

• Creator: Reimers, Natalie ; Pantel, Klaus

Further information

• DOI: 10.1515/cclm-2018-0610
• URN: urn:nbn:de:101:1-2022053115160197276565
• Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 15.08.2025, 7:21 AM CEST